Sanofi offers VRS to 800 employees at two units in Telangana

A Sanofi spokesperson told ET that a glut of supplies added during Covid-19 and the struggle to win contracts from Unicef for its critical 5-in-1 pediatric vaccine Shan5 forced the company to assess its India operations.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/tluCfYB
via IFTTT